The Beneficiaries of GLP-1 Drugs Across Industries Health Insurers and the Cost of Obesity Source: McKinsey 4 Although weight loss has been the main focus in the analyses of these drugs so far, it is important to bear in mind that with them comes the improvement in other measurements of health, such as blood glucose levels, cardiovascular parameters, cholesterol and triglyceride levels
The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Fatima Cody Stanford, MD, associate professor of medicine and pediatrics at Harvard Medical School, who was not involved in the study
Stress management through yoga, meditation, or breathing exercises can calm your enteric nervous systemthe "gut brain" that controls digestionand directly reduce bloating episodes triggered by anxiety
Insulin Feedback: The insulin secreted by -cells acts as a negative feedback signal to further inhibit glucagon release from -cells (Zheng et al., 2024)
Reduced appetite does not always lead to immediate weight loss